DJ

Lykos Books Challenges Convention With Sci-Fi Debut From Physician-Turned-Author Dr. Petros Georgiou

Dr. Petros Georgiou, a U.S.-based physician, makes his literary debut with Second Chance, a thought-provoking dystopian science fiction novel, launching on June 3rd, 2025. The book explores the complexities of time travel, AI, and rewriting one’s past.

United States, 4th Apr 2025 – Set against a dystopian backdrop, Second Chance follows characters navigating moral uncertainty, technological upheaval, and personal transformation. While fictional, the story is rooted in real-world parallels. Drawing from his personal experience as an immigrant and physician in post-pandemic New York, Dr. Georgiou weaves cultural nuance, emotional truth, and speculative science into a cohesive narrative. The result is a genre piece that remains grounded in human emotion and urban realism.

The narrative is also informed by generational insights, especially for readers who matured during the early 2000s. Themes of urban survival, disconnection, and the desire for self-reinvention underpin the story’s central time travel dilemma. Rather than glorifying technological mastery, Second Chance uses science fiction as a lens to examine identity, loss, and the perennial quest for meaning.

 

 

A Personal Touch: Dr. Georgiou Narrates the Audiobook

Dr. Georgiou’s decision to narrate the audiobook version of Second Chance further underscores his commitment to an immersive and personal storytelling experience. His vocal interpretation adds another dimension to the novel, inviting listeners to engage with the story in a format that deepens emotional impact and narrative accessibility. This direct engagement with readers, both in print and in audio, is part of his larger mission to “put style back into storytelling.”

 

 

Lykos Books: A Publishing Model That Prioritizes Innovation

In a publishing landscape where marketability often takes precedence over innovation, Lykos Books seeks to restore the balance by prioritizing narratives that spark thought and dialogue. “Writers today face a dual challenge—getting published and staying true to their vision,” said Dr. Georgiou. “At Lykos Books, we aim to support authors who want to push boundaries without compromising the heart of their stories.”

This philosophy also guides the company’s broader publishing goals. Lykos Books intends to build a collaborative ecosystem that connects like-minded writers with the resources they need to bring their visions to life. Rather than operating as a traditional press, the company positions itself as a hub for experimentation, offering editorial support and creative freedom for writers passionate about the intersection of science, ethics, and imagination.

Science Fiction as a Platform for Critical Reflection

With society confronting real-world advances in artificial intelligence, robotics, and the prospect of space exploration, Dr. Georgiou believes that science fiction must evolve to meet these new realities. He views the genre not as escapism, but as a platform for critical reflection and social critique. “Science fiction should not just predict the future—it should prepare us to engage with it thoughtfully,” he explained.

The ethos behind Lykos Books reflects this conviction. Its publishing model prioritizes intellectual rigor and artistic merit, encouraging narratives that explore the future through a philosophical and scientific lens. Rather than commercial formulas, the focus remains on originality and relevance. This is particularly important for younger writers, who often struggle to gain traction in an industry dominated by established names and genre conventions.

Dr. Georgiou’s Personal Journey and Vision

Dr. Georgiou’s personal story adds credibility to his publishing vision. As someone who transitioned from medicine to literature, he embodies the very themes he promotes—reinvention, exploration, and the power of narrative to heal and connect. His journey is one of interdisciplinary evolution, blending the empirical world of clinical science with the imaginative domain of speculative fiction.

The timing of this launch also aligns with a new academic chapter in Dr. Georgiou’s life. He has been accepted to the Harvard T.H. Chan School of Public Health, an experience he expects will further shape his approach to science-driven storytelling. He views this next step as a way to deepen his understanding of global systems and human behavior, insights that will likely influence the sequel to Second Chance.

A Literary Movement for Transformation

As the literary world grapples with questions about inclusivity, innovation, and the role of emerging technologies in narrative craft, Lykos Books stands out for its commitment to bold storytelling grounded in real-world expertise. The company offers a space for new authors to challenge assumptions, explore ethical questions, and present fresh visions of the future that reflect the uncertainties of the present.

Through Second Chance and future titles, Dr. Georgiou hopes to create a literary movement centered on transformation—both personal and collective. With themes that speak to the complexity of identity, the weight of history, and the promise of change, Lykos Books aims to reshape how science fiction is imagined, written, and shared.

For readers and writers alike, Lykos Books offers more than just a publishing platform—it offers a second chance to tell meaningful stories in meaningful ways. Second Chance will be available on all online platforms on June 3rd, 2025

About Lykos Books
Lykos Books is an independent publishing house founded by Dr. Petros Georgiou with the aim of creating a platform for emerging authors to explore thought-provoking science fiction that tackles contemporary issues. The publishing house prioritizes originality, intellectual rigor, and artistic merit, with a focus on stories that explore the intersection of science, ethics, and speculative imagination.

 

Media Contact

Organization: Lykos Books

Contact Person: Petros Georgiou

Website: https://lykosbooks.com

Email: Send Email

Country: United States

Release Id: 04042526040

Leave a Reply

Your email address will not be published. Required fields are marked *